Poloxamer Gel

Closed Pre-Solicitation Posted

Solicitation number
HT9425-24-LBA-RFI-01
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Jbsa Lackland, Texas, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Army Medical Command is seeking information and capabilities from industry to develop a novel thermoresponsive, bioadhesive, antibiotic gel to prevent infection in combat-related extremity wound injuries. Specifically, the Army is looking to use the gel to target antibiotic-resistant bacteria such as Acinetobacter baumannii and MRSA. The required research and development includes product development and animal model testing. Interested parties should submit their capability statements electronically by April 19, 2024. This Request for Information (RFI) is for information and planning purposes only and does not constitute a solicitation or obligation to award a contract.

The NAICS code for this potential action is 541715 - Research and Development in the Physical, Engineering, and Life Sciences. There is no set-aside designation provided in the pre-solicitation notice. The notice does not name any potential incumbents or provide any information on award values or budget ranges.

Notice text

Please see the attached document for information and details.

Files

File Type Posted
HT9425-24-RFI-LBA-01.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination Frederick, Maryland, United States · NAICS 541715 — No set-aside
Request for Information – Prophylactic Platform for Medical Countermeasures Frederick, Maryland 21702, United States · NAICS 541715 ACC Aberdeen Proving Ground No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity